.
MergerLinks Header Logo

New Deal


Announced

Synova Capital to invest in Preventx.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

clinical laboratories

Private Equity

Single Bidder

Pending

United Kingdom

Private

Acquisition

Friendly

Biotechnology

Minority

Synopsis

Edit

Synova Capital agreed to invest in Preventx, provider of online-led sexual health testing and diagnostic services and the only UK company with a fully integrated laboratory model. Financial terms were not disclosed. This is the first investment for Synova's latest vehicle. The GP held a first and final close for Synova IV on its £365m ($463m) hard-cap in June.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US